ACM
DGX icon

AlphaStar Capital Management’s Quest Diagnostics DGX Stock Holding History

AlphaStar Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,481
Closed -$207K – 212
2018
Q4 		$207K Sell
2,481
-263
-10% -$24.7K 0.07% 199
2018
Q3 		$296K Sell
2,744
-701
-20% -$76.9K 0.09% 189
2018
Q2 		$379K Buy
+3,445
New +$359K 0.12% 158

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaStar Capital Management's DGX Position: Q1 2019 in Review

AlphaStar Capital Management sold out of Quest Diagnostics (DGX) in Q1 2019, closing a stake of 2,481 shares — an estimated $207K sold.

AlphaStar Capital Management first reported a position in DGX in Q2 2018 and held it in 3 quarters. The position peaked at $379K in Q2 2018. 656 funds tracked by Wall St. Rank hold DGX as of Q1 2019.

  • AlphaStar Capital Management reported no remaining Quest Diagnostics position as of Q1 2019 after selling out during the quarter.
  • AlphaStar Capital Management sold 2,481 Quest Diagnostics shares in Q1 2019, an estimated $207K.
  • AlphaStar Capital Management first reported a position in Quest Diagnostics in Q2 2018 and held it in 3 quarters.
  • AlphaStar Capital Management's Quest Diagnostics position peaked at $379K in Q2 2018.
  • 656 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2019.

Based on AlphaStar Capital Management's 13F filing for Q1 2019, filed 25 Apr 2019.